PDF

The Pharmaceutical Launch Excellence Summit Europe 2026 is where the industry's most influential launch leaders converge to decode what truly drives commercial success today. In a closed‑door, practitioner‑only environment, senior leaders from Pfizer, Takeda, Novo Nordisk, Biogen, Sandoz, CSL, BMS and more share the real strategies, frameworks, and lessons shaping Europe's most competitive launches across oncology, immunology, obesity, rare diseases, and biosimilars.

Across three days of case studies, workshops, a focus day and cross‑functional roundtables, you'll gain practical, repeatable approaches to accelerate adoption, strengthen launch readiness, navigate evolving policy and access pressures, and embed AI‑powered decision‑making into your launch strategy. If you're responsible for delivering measurable launch impact, #PHLEX is the one event you cannot afford to miss.

Put your brand in front of the leaders shaping the future of pharmaceutical launches. The Pharmaceutical Launch Excellence Summit brings together senior decision-makers across launch excellence, commercial strategy, market access, marketing and more from leading pharma organisations. Our sponsorship opportunities are designed to help you build credibility, create high-value connections and generate new business with the people actively shaping launch strategy and investment.

Download the Sponsorship Prospectus to explore the audience, partnership opportunities and ways your organisation can get involved.

Learn how pharmaceutical companies are using AI to improve patient targeting, forecasting, market access, and launch execution. This practical insight brief explores the AI capabilities helping launch teams make faster decisions, identify opportunities earlier, and improve commercial performance.

You'll learn:

• How AI improves patient identification and segmentation
• Smarter forecasting and scenario planning techniques
• AI applications in pricing and market access
• Early detection of market and competitive signals
• Real-time launch performance monitoringStrategies for better commercial decision-making

Download your complimentary copy of the industry report today for an in-depth analysis of the trends, challenges and market forces shaping pharmaceutical launches. Explore the latest insights on market access, pricing and reimbursement, AI, launch execution, and evolving regulatory requirements, alongside real-world examples from leading pharmaceutical organisations.

• Why up to two-thirds of pharmaceutical launches fail to meet expectations and the common execution gaps separating launch readiness from launch success.
• How the first 6-12 months now determine long-term launch performance, with early access, adoption and payer decisions becoming increasingly difficult to reverse.
• The impact of the EU HTA Regulation and Joint Clinical Assessments, and what launch teams need to do now to prepare evidence strategies for a changing European market access landscape.
• How pricing, reimbursement and access pressures are reshaping launch strategy across Europe and the US, from Medicare negotiations to increasing payer scrutiny and value-based assessments.
• The rise of obesity, oncology and specialty therapies, with oncology spend forecast to exceed $440 billion globally by 2029 and obesity medicines projected to reach up to $280 billion by 2030.
• Practical AI use cases already improving launch performance, including forecasting, omnichannel optimisation, field enablement, medical insight generation and early signal detection.
• How leading organisations are evolving launch operating models, moving from milestone-based launch planning to continuous launch performance management.
• Real-world lessons from companies including AstraZeneca, Roche, Novartis, Teva and Sandoz on evidence generation, market access, launch sequencing and supply resilience
  

Explore Pharma Launch Excellence: 2025 vs 2026

Discover how pharmaceutical launch strategies are evolving with our latest comparative analysis. This report highlights key market trends, emerging therapeutic areas, and the factors behind launch failures and successes, giving you actionable insights to plan effectively for 2026. Read the full analysis now

Pharma Launch Readiness Checklist: Your 10-Step Guide to Pharma Launch Success

Is your pharma launch ready? This concise checklist distills the key insights from our 2025 Global State of Pharma Launch Excellence Industry Report into a practical guide for launch leaders, brand teams, and cross-functional stakeholders. Learn how to navigate complexity, avoid common pitfalls, and drive long-term success, from strategy and market entry to post-launch performance. Download your copy now and future-proof your next launch>>